Orchard Therapeutics North America
At a glance
EmployeesNot reported
In business since2015
HeadquartersBoston, MA
SAM.gov UEITYBHELHYRHB7
Orchard Therapeutics develops HSC gene therapy for severe genetic diseases, including metachromatic leukodystrophy. The company applies its HSC gene therapy platform to treat patients with severe and other genetic diseases.
Summarized from the company’s own website
Their plants
2 FACILITIES| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Orchard Therapeutics North America INC | Menlo Park | CA | — | UNVERIFIED |
| Orchard Therapeutics North America | Boston | MA | — | ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.